Stress Relief Techniques: p38 MAPK Determines the Balance of Cell Cycle and Apoptosis Pathways.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
02 10 2021
Historique:
received: 23 07 2021
revised: 23 09 2021
accepted: 30 09 2021
entrez: 23 10 2021
pubmed: 24 10 2021
medline: 19 1 2022
Statut: epublish

Résumé

Protein signaling networks are formed from diverse and inter-connected cell signaling pathways converging into webs of function and regulation. These signaling pathways both receive and conduct molecular messages, often by a series of post-translation modifications such as phosphorylation or through protein-protein interactions via intrinsic motifs. The mitogen activated protein kinases (MAPKs) are components of kinase cascades that transmit signals through phosphorylation. There are several MAPK subfamilies, and one subfamily is the stress-activated protein kinases, which in mammals is the p38 family. The p38 enzymes mediate a variety of cellular outcomes including DNA repair, cell survival/cell fate decisions, and cell cycle arrest. The cell cycle is itself a signaling system that precisely controls DNA replication, chromosome segregation, and cellular division. Another indispensable cell function influenced by the p38 stress response is programmed cell death (apoptosis). As the regulators of cell survival, the BCL2 family of proteins and their dynamics are exquisitely sensitive to cell stress. The BCL2 family forms a protein-protein interaction network divided into anti-apoptotic and pro-apoptotic members, and the balance of binding between these two sides determines cell survival. Here, we discuss the intersections among the p38 MAPK, cell cycle, and apoptosis signaling pathways.

Identifiants

pubmed: 34680077
pii: biom11101444
doi: 10.3390/biom11101444
pmc: PMC8533283
pii:
doi:

Substances chimiques

BCL2 protein, human 0
Proto-Oncogene Proteins c-bcl-2 0
p38 Mitogen-Activated Protein Kinases EC 2.7.11.24

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIGMS NIH HHS
ID : R01GM102413
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM083024
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009156
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35GM141833
Pays : United States
Organisme : NCI NIH HHS
ID : T32CA009156
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM102413
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01GM083024
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM141833
Pays : United States

Références

Cell Death Dis. 2020 Feb 28;11(2):156
pubmed: 32111816
Mol Cell Biol. 2010 Aug;30(15):3816-26
pubmed: 20516219
Oncogene. 2008 Dec;27 Suppl 1:S2-19
pubmed: 19641503
Nat Commun. 2015 Jul 29;6:7901
pubmed: 26219591
Biochem Biophys Res Commun. 2010 Apr 16;394(4):976-80
pubmed: 20307495
J Biol Chem. 2000 Nov 10;275(45):35091-7
pubmed: 10952989
Biochem J. 2012 Jul 1;445(1):1-10
pubmed: 22702973
Science. 2002 Dec 6;298(5600):1912-34
pubmed: 12471243
Cancer Cell. 2002 Sep;2(3):183-92
pubmed: 12242151
Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):16856-61
pubmed: 24082115
Cell Mol Life Sci. 2008 Nov;65(22):3525-44
pubmed: 18668205
Nat Cell Biol. 2017 Oct;19(10):1237-1247
pubmed: 28920952
Nature. 2011 Mar 3;471(7336):110-4
pubmed: 21368834
Cancer Cell. 2018 Jun 11;33(6):1094-1110.e8
pubmed: 29805078
EMBO J. 2010 Jul 21;29(14):2407-20
pubmed: 20526282
Protein Cell. 2011 Nov;2(11):864-78
pubmed: 22180086
EMBO J. 2006 Feb 22;25(4):763-73
pubmed: 16456545
Nature. 1986 Oct 16-22;323(6089):643-6
pubmed: 2877398
J Exp Med. 2017 Feb;214(2):491-510
pubmed: 28057804
Curr Opin Cell Biol. 2009 Apr;21(2):317-24
pubmed: 19217767
Cell Death Differ. 2018 Jan;25(1):56-64
pubmed: 29077093
J Biol Chem. 1995 Oct 6;270(40):23589-97
pubmed: 7559524
J Biol Chem. 2011 Nov 18;286(46):39829-35
pubmed: 21953453
Cell Commun Signal. 2012 Mar 09;10:6
pubmed: 22404972
Mol Cell. 2006 Mar 17;21(6):749-60
pubmed: 16543145
Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3516-20
pubmed: 7682708
Int J Mol Sci. 2020 Mar 28;21(7):
pubmed: 32231094
Cell Rep. 2014 May 8;7(3):661-71
pubmed: 24767991
J Biol Chem. 2002 Aug 16;277(33):29792-802
pubmed: 12058028
Future Oncol. 2017 Jun;13(14):1223-1232
pubmed: 28492339
Cell. 1983 Jun;33(2):389-96
pubmed: 6134587
Curr Top Microbiol Immunol. 1996;208:1-30
pubmed: 8575210
Elife. 2014 Jun 04;3:
pubmed: 24876129
Cell Death Differ. 2018 Jan;25(1):65-80
pubmed: 29149100
Cell Stress. 2021 Apr 26;5(6):76-85
pubmed: 34124582
Cancer Cell Int. 2020 Jun 3;20:213
pubmed: 32518522
Oncogene. 2001 Oct 25;20(48):6983-93
pubmed: 11704823
Leukemia. 2002 Apr;16(4):444-54
pubmed: 11960321
Mol Cell. 2019 Mar 7;73(5):985-1000.e6
pubmed: 30711375
Biochem J. 2017 Oct 23;474(21):3643-3657
pubmed: 29061914
Mol Cell. 2010 Feb 12;37(3):299-310
pubmed: 20159550
Apoptosis. 2013 Jul;18(7):851-60
pubmed: 23456625
Nat Cell Biol. 2012 Mar 25;14(5):535-41
pubmed: 22446738
Cell Death Differ. 2006 Aug;13(8):1351-9
pubmed: 16763616
J Cell Sci. 2004 May 1;117(Pt 11):2173-81
pubmed: 15126619
Prostate. 2011 Aug 1;71(11):1158-66
pubmed: 21656826
Cell. 1991 Jun 14;65(6):1053-61
pubmed: 1828392
Mol Cell. 2016 Oct 6;64(1):25-36
pubmed: 27642049
Mol Cell. 2005 Jan 7;17(1):37-48
pubmed: 15629715
Oncogene. 2007 May 14;26(22):3097-9
pubmed: 17496908
Nature. 2001 May 3;411(6833):102-7
pubmed: 11333986
J Biol Chem. 2001 Oct 19;276(42):39115-22
pubmed: 11495913
EMBO J. 2003 Oct 15;22(20):5459-70
pubmed: 14532118
Cell Cycle. 2006 Aug;5(15):1649-53
pubmed: 16861915
J Biol Chem. 2004 Mar 5;279(10):8627-34
pubmed: 14684737
Development. 2013 Aug;140(15):3118-27
pubmed: 23824576
Mol Cell. 2017 Jun 1;66(5):698-710.e5
pubmed: 28506461
Cell. 1989 Sep 22;58(6):1107-19
pubmed: 2673544
Cell Death Dis. 2013 Feb 28;4:e515
pubmed: 23449451
Cell. 2005 Aug 26;122(4):593-603
pubmed: 16122426
Mol Carcinog. 2012 Jul;51(7):576-85
pubmed: 21769948
Genes Dev. 1994 Jul 1;8(13):1514-25
pubmed: 7958836
J Biol Chem. 1988 Apr 15;263(11):5396-401
pubmed: 3258598
Oncogene. 2002 Nov 7;21(51):7765-75
pubmed: 12420213
IUBMB Life. 2007 Jul;59(7):419-26
pubmed: 17654117
Nat Rev Mol Cell Biol. 2021 May;22(5):346-366
pubmed: 33504982
Nature. 1994 May 26;369(6478):321-3
pubmed: 8183370
Cell Cycle. 2007 Sep 1;6(17):2171-7
pubmed: 17882791
Science. 1998 Apr 24;280(5363):599-602
pubmed: 9554853
Nature. 1988 Nov 17;336(6196):259-61
pubmed: 2848196
Cell. 2005 Jul 1;121(7):1085-95
pubmed: 15989957
Genes Dev. 2003 Jun 15;17(12):1475-86
pubmed: 12783855
Int J Mol Sci. 2020 Mar 11;21(6):
pubmed: 32168915
Cell Cycle. 2014;13(22):3611-7
pubmed: 25483096
Cell. 2005 Aug 26;122(4):579-91
pubmed: 16122425
Cancer Cell. 2009 Mar 3;15(3):184-94
pubmed: 19249677
Science. 2004 Nov 26;306(5701):1511-2
pubmed: 15567851
Mol Cell Biol. 2000 Jul;20(13):4745-53
pubmed: 10848600
Oncogene. 2008 Jul 31;27(33):4557-68
pubmed: 18408751
Neurochem Int. 2013 Sep;63(3):133-40
pubmed: 23714208
Cell. 1993 Aug 27;74(4):609-19
pubmed: 8358790
Cell Death Differ. 2008 Sep;15(9):1450-9
pubmed: 18437159
J Biol Chem. 2004 Mar 19;279(12):11957-66
pubmed: 14704147
EMBO J. 1996 Dec 16;15(24):6991-7001
pubmed: 9003775
Nat Rev Cancer. 2009 Aug;9(8):537-49
pubmed: 19629069
Oncotarget. 2015 Nov 10;6(35):38181-94
pubmed: 26431330
Cell Stem Cell. 2016 Mar 3;18(3):396-409
pubmed: 26748418
Cell Cycle. 2006 Apr;5(8):824-8
pubmed: 16627995
Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4504-8
pubmed: 8633098
Nat Cell Biol. 2017 Oct;19(10):1248-1259
pubmed: 28920954
Blood. 2003 Nov 1;102(9):3179-85
pubmed: 12855558
Cell Cycle. 2009 Sep 1;8(17):2692-6
pubmed: 19652530
Cell. 2020 Jul 23;182(2):404-416.e14
pubmed: 32610081
Nat Rev Mol Cell Biol. 2007 Jul;8(7):530-41
pubmed: 17585314
Trends Cell Biol. 1994 Nov;4(11):399-403
pubmed: 14731816
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
Pharmaceuticals (Basel). 2020 Nov 24;13(12):
pubmed: 33255177
Dev Cell. 2008 Feb;14(2):159-69
pubmed: 18267085
Biochim Biophys Acta. 2007 Aug;1773(8):1358-75
pubmed: 17481747
Oncogene. 2005 Nov 24;24(53):7941-5
pubmed: 16027723
EMBO J. 2018 Sep 3;37(17):
pubmed: 29987118
Oncogene. 2002 Feb 21;21(9):1359-69
pubmed: 11857079
Oncogene. 2011 Feb 10;30(6):701-13
pubmed: 20935673
Genes Dev. 2013 May 1;27(9):1003-15
pubmed: 23618872
J Biol Chem. 2011 Jan 7;286(1):491-501
pubmed: 21041309
J Biol Chem. 2006 Sep 1;281(35):25215-22
pubmed: 16818494
Nature. 2019 Apr;568(7753):557-560
pubmed: 30971822
FEBS Lett. 2006 Jun 12;580(14):3539-44
pubmed: 16730715
Mol Biol Cell. 2010 Jul 1;21(13):2150-60
pubmed: 20462950
Trends Biochem Sci. 2000 Jun;25(6):257-60
pubmed: 10838561
Cells. 2019 Apr 12;8(4):
pubmed: 31013740
Cancer Cell. 2014 Apr 14;25(4):484-500
pubmed: 24684847
Mol Cell Biol. 2007 Jun;27(11):4006-17
pubmed: 17387146
BMC Cancer. 2008 Dec 18;8:375
pubmed: 19091131
Proc Natl Acad Sci U S A. 1987 Mar;84(6):1502-6
pubmed: 2951732
Mol Cell. 2010 Oct 8;40(1):34-49
pubmed: 20932473
Genes Dev. 2000 Mar 1;14(5):574-84
pubmed: 10716945
Apoptosis. 2008 Jun;13(6):803-10
pubmed: 18465250
Cancer Res. 2001 Jan 15;61(2):659-65
pubmed: 11212265
Cell Death Differ. 2010 Aug;17(8):1288-301
pubmed: 20168333
EMBO J. 1997 Aug 1;16(15):4628-38
pubmed: 9303307
Science. 1990 Jul 6;249(4964):64-7
pubmed: 2164259
J Biol Chem. 1997 May 9;272(19):12738-46
pubmed: 9139732
Apoptosis. 2007 Sep;12(9):1733-42
pubmed: 17505786
PLoS One. 2013 Oct 11;8(10):e77495
pubmed: 24147007
Mol Cell Biol. 1999 May;19(5):3246-56
pubmed: 10207050
Mol Biol Cell. 2003 May;14(5):2071-87
pubmed: 12802076
Cell Death Differ. 2018 Jan;25(1):37-45
pubmed: 29099482
Oncotarget. 2017 Jul 25;8(30):49783-49795
pubmed: 28572537
EMBO J. 1999 Dec 1;18(23):6845-54
pubmed: 10581258
Cancer Res. 2002 Sep 1;62(17):5076-82
pubmed: 12208764
Cold Spring Harb Perspect Biol. 2013 Mar 01;5(3):a008904
pubmed: 23457258
J Biol Chem. 2000 Dec 15;275(50):39458-65
pubmed: 10978339
Curr Opin Genet Dev. 2002 Feb;12(1):92-7
pubmed: 11790561
Int J Biol Sci. 2009;5(1):44-51
pubmed: 19159010
J Cell Sci. 2011 Aug 15;124(Pt 16):2816-25
pubmed: 21807946
Trends Biochem Sci. 2015 Dec;40(12):736-748
pubmed: 26541461

Auteurs

Robert H Whitaker (RH)

Department of Biochemistry & Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Jeanette Gowen Cook (JG)

Department of Biochemistry & Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH